HOT : Venetian Gondola Boat , Macau Tower , Galaxy 3 In 1 Package SINGAPORE, March 16, 2016 /PRNewswire/ -- With growing populations and increasingly higher global healthcare standards, the biopharma landscape in Asia is changing. How can we cope with these changes, and what do we need to be prepared for as we move towards 2020? AstraZeneca and ASLAN Pharmaceuticals will lead a keynote panel discussion on the opening day of Biopharma Asia Convention conference and expo taking place at Suntec Singapore on 23 March 2016. Leading the panel discussion will be Ajay Gautam, Executive Director and Head, Asia Pacific and Emerging Markets, Scientific Partnering and Alliances at AstraZeneca China and Carl Firth, Chief Executive Officer of ASLAN Pharmaceuticals in Singapore. The panel will be moderated by Yariv Hefez, VP Strategic Development, Business Development, Portfolio Management and Partnering (Biosimilar), Merck, Switzerland. On Day 2 of the conference (24 March 2016), Deputy Director of the Singapore Economic Development Board, Ms Weng Si Ho will keynote the conference with the topic: Creating an international Biomedical Sciences hub: Lessons learned and successes achieved. Following several years of enhanced investment in developing a biomedical sciences hub, how can we measure its success? Using Singapore as the case study, she will provide an insight into the challenges faced in establishing Singapore as a key biomedical sciences hub, the successes achieved so far and plans for the future. Speakers at the 2016 edition of Biopharma Asia Convention come from Asia Pacific and globally. They include:
The conference is expected to attract over 600 attendees with focused streams on partnering, pricing and policies, clinical trials, supply chain, manufacturing, vaccine, orphan drugs, biosimilars and antibodies. 5 startup biotechs -- Novogen, Cennerv Pharma, Yisheng Biopharma, Sphaera Pharma, Hummingbird Bioscience -- will also be present to pitch their start-ups to leading investors and pharmas. Alongside the conference is an exhibition with over 50 exhibitors showcasing products, solutions and services from companies like Merck, Marken, GE Healthcare, Fedex, NiHR (CRN), PRA Healthsciences, Lion Bridge Lifesciences and more. Two on-floor theatres will feature the latest research and technology findings by leading Asian research and academic institutions. About BioPharma Asia Convention About Terrapinn Note: Press registration for the conference is compulsory and advance scheduling for speaker/ sponsor interviews is recommended. Final issuance of press passes is subjected to Terrapinn's discretion. For your press pass, please contact the following: SALE : SKY100 , Madame Tussauds , HK 3D Museun ; News Sources
|